Navigation Links
MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices
Date:11/24/2009

businesses that GETINGE acquired from Datascope. MAQUET Cardiovascular provides healthcare professionals with products in four business units: Cardiopulmonary (perfusion products), Cardiac Surgery (clampless beating heart and endoscopic vessel harvesting), Vascular Interventions (grafts for vascular surgery), and Cardiac Assist (intra-aortic balloon counterpulsation therapy).

About MAQUET

The MAQUET Group is the global market leader for Medical Systems, focusing on the Operating Room (OR) and Intensive Care Unit (ICU). The integrated products of MAQUET are specially designed to deliver optimal clinical treatment and therapy concepts within acute care hospitals. MAQUET provides innovative medical solutions from three divisions:

  • Cardiovascular with products for cardiac assist (intra-aortic balloon counterpulsation therapy), coronary artery bypass surgery, heart valve repair, aneurysm and vascular repair, peripheral interventions and extracorporeal circulation.
  • Critical Care for intensive care ventilators and anesthesia machines.
  • Surgical Workplaces for OR tables, lights and ceiling service units, prefabricated OR and ICU suites, as well as telemedicine for the OR integration.

MAQUET is a subsidiary of the publicly-listed Swedish GETINGE GROUP, a company with over $2.8 billion in revenues (2008 fiscal year) and 12,800 employees worldwide. In 2008 MAQUET itself generated pro-forma revenues (including the acquisition of Datascope Corp.) of over $1.4 billion. The company now has 5,000 employees in 35 international sales and service organizations, as well as a network of more than 200 sales representatives.

www.maquet.com

www.getingegroup.com

MAQUET - The Gold Standard.

SOURCE MAQUET Cardiovascular LLC


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
2. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
3. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
4. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
5. Cardiologists Tackle Next Frontier in Cardiovascular Disease
6. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
7. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
8. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
9. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
10. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
11. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... - Canadians face wait times of over 460 days in order to ... according to a new IMS Brogan report commissioned by ... out of 18 similar OECD countries. "It,s unimaginable to ... medicines were included in public plans, ranking Canada ... Skinner , Rx&D Executive Director, Health and Economic Policy. ...
(Date:5/21/2015)...  BioClinica®, Inc., a leading specialty clinical trials ... partnered with Kinapse to accelerate Risk-Based Monitoring (RBM) ... Intelligent Monitoring solution. "Implementing a ... in clinical research," BioClinica CEO John Hubbard ... it helps move the industry forward with intelligent ...
(Date:5/21/2015)... May 21, 2015  Abaxis, Inc. (NasdaqGS: ABAX ... systems, announced today that Ross Taylor , vice ... the role of chief financial officer effective August 1, ... Veterinary Conference on Wednesday, May 27, 2015 at 10:20 ... Peninsula Hotel in New York City ...
Breaking Medicine Technology:Canadians lagging well behind similar countries on access to new medicines: report 2Canadians lagging well behind similar countries on access to new medicines: report 3BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation 2BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation 3
... drug recently approved by the U.S. Food and Drug Administration ... discovered more than a decade earlier at St. Jude Children,s ... Jude can be translated into therapies and tests that in ... drug is Xalkori (crizotinib). The FDA approved Xalkori in August ...
... , Pa., Sept. 29, 2011 Medical Alarm ... received a new commitment for capital that will be ... for the MediPendant™, the first fully-monitored medical alarm system ... the pendant. Approximately one third of this private investment ...
Cached Medicine Technology:St. Jude Children's Research Hospital Discovery Aided Quest for Adult Cancer Drug 2St. Jude Children's Research Hospital Discovery Aided Quest for Adult Cancer Drug 3Medical Alarm Concepts Receives Growth Capital Injection and Commitment for Future Funding 2Medical Alarm Concepts Receives Growth Capital Injection and Commitment for Future Funding 3
(Date:5/22/2015)... 2015 A new program for the ... the field of Physical Therapy. , James Earl ... mystery out of physical therapy and discusses how the ... for a variety of ailments and injuries. Physical ... exercise plan that enhances daily activities such as house ...
(Date:5/22/2015)... In efforts to offer full and ... particular muscles stretches has been a large focus over ... now complete, Chunk Fitness envisions a mid-June launch of ... and released at a later point in time. The ... http://www.chunkfitness.com/stretches . , About the Company: Chunk Fitness was ...
(Date:5/22/2015)... May 22, 2015 Pro3rd Impression ... designed exclusively for Final Cut Pro X. Pro3rd Impression's ... design. , Intuitive on-screen-controls allow users to customize ... Reflections, colors, layouts, and much more can be edited ... , Pro3rd Impression comes packed with 30 ...
(Date:5/21/2015)... Her popular Love Seminar will be coming ... San Gabriel on Saturday, May 23rd. , A statement ... and women who are unhappy in their relationships has been, ... singles think that their biggest problem is not being able ... one relationship to another trying to find the right person. ...
(Date:5/21/2015)... 2015 The Johns Hopkins Alliance for ... Baltimore Commercial Advisory Board has selected a research project ... as one of two $50,000 Abell Foundation Award for ... known as Anklebot. Developed by the VA Maryland ... the University of Maryland School of Medicine and Massachusetts ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2Health News:Bestselling Author Sheds Light on Why Modern Dating is Hurting People's Chances of Finding a Lasting Relationship 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3
... ZION, Ill., June 2 The following was,released by Cancer Treatment ... 2008, -- An inspirational and extraordinary celebration and ... their five-year triumph over cancer at ... Center -- Tree-Planting Ceremony -- ...
... Improve Health Systems in ... Developing Countries, NEW ... improve the health of poor and,vulnerable people around the world -- ... a major international conference hosted by the,Rockefeller Foundation. The conference, Making ...
... Inc.),a privately held medical device company and leader in ... the OSSAnchor(TM),Grip, a nitinol implant designed to approximate soft ... in the family of OSSAnchor(TM) nitinol soft,tissue implants, designed ... a,nitinol implant with aggressive barbs on the legs for ...
... PRINCETON, N.J., June 2 The New Jersey,Hospital ... as its,general counsel, NJHA,s president-designee Betsy Ryan announced., ... Counsel Karen Ali,who has been named NJHA,s vice ... counsel, Jacobs will provide direction on all legal ...
... As America,s baby boomers continue to age, the ... is expected to double to 70 million by 2030. ... conditions, including Alzheimer,s, heart disease, diabetes and cancer, is ... particularly a diet including phytonutrient-rich fruits, vegetables and their ...
... June 2 The Walk on the Capitol,is proud ... and The,Sopranos, as special guest speaker for our National ... - Walk on the Capitol is a,history-making awareness event ... bring National attention to the obesity epidemic and,the need ...
Cached Medicine News:Health News:Five-Year Cancer Survivors Will Celebrate Life(R) at Cancer Treatment Centers of America(R) 2Health News:Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference 2Health News:Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference 3Health News:Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference 4Health News:BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor 2Health News:Drinking polyphenol-rich Concord grape juice may improve memory in older adults 2Health News:Television Star Caitlin Van Zandt Signs-on as Special Guest Speaker for National Obesity Awareness Event in Washington, DC, on June 17 2
Urea nitrogen (BUN) liquid reagent is used for the kinetic quantitative determination of Urea Nitrogen (BUN) in human serum used in routine examination and monitoring of therapy and relapses....
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
Intended for the quantitative determination of direct bilirubin in serum. Modified EvelynMalloy Method. Endpoint Reaction. Wavelength: 555 nm. Linearity: 20 mg/dl (340 mol/l)...
... microplate spectrophotometer designed specifically to run 24 ... With rugged hardware, proven optical performance and ... of traditional spectrophotometry to obtain results quickly, ... read up to eight, 1 cm Biocell ...
Medicine Products: